Carregant...

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results

This report presents our experience with T therapy in a cohort of T-deficient men on active surveillance (AS) for Gleason 3 + 3 and Gleason 3 + 4 prostate cancer (PCa). A retrospective chart review identified 28 men with T deficiency who underwent T therapy (T group) for at least 6 months while on A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Asian J Androl
Autors principals: Kacker, Ravi, Hult, Mariam, San Francisco, Ignacio F, Conners, William P, Rojas, Pablo A, Dewolf, William C, Morgentaler, Abraham
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4736350/
https://ncbi.nlm.nih.gov/pubmed/26306850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.160270
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!